Renata Tamburic

Renata Tamburic is a qualified gastroenterologist currently working at the University Clinical Centre of the Republic of Srpska since January 2023 and has extensive experience in clinical study coordination across various pharmaceutical companies. Renata serves as a Clinical Study Coordinator at InDex Pharmaceuticals AB for the CONCLUDE study on Cobitolimod and at The Janssen Pharmaceutical Companies of Johnson & Johnson for studies related to Guselkumab in Crohn's Disease. Additionally, Renata holds the position of Principal Investigator at Celgene Switzerland Investment Sarl, overseeing a Phase 3 study on Ozanidmod for Crohn's Disease. Renata's medical career includes roles as an Internal Medicine Specialist and a Medical Doctor at the University Clinical Center RS, alongside pursuing PhD studies at the University of Novi Sad in 2013.